SEC Form 4 · accession 0001104659-17-004977
SELECTA BIOSCIENCES INC · SELB
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Lloyd P. Johnston
Officer — COO AND SVP, R&D
Period of report
Jan 23, 2017
Accepted (ET)
Jan 30, 2017 · 4:54 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001453687
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Jan 23, 2017 | M | 15,000 | $0.39 | A | 16,606 | D | |
| Common StockF2 | Jan 23, 2017 | S | 11,110 | $13.95 | D | 5,496 | D | |
| Common StockF3 | Jan 23, 2017 | S | 3,890 | $14.17 | D | 1,606 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Employee Stock Option (right to buy)F4 | $0.39 | Jan 23, 2017 | M | 15,000 | D | — | Jul 6, 2018 | Common Stock | 15,000 | 13,205 | D |
Explanation of responses
- F1The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person.
- F2The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $13.95 to $14.00, inclusive. The reporting person undertakes to provide to Issuer, any security holder of Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (1) and (2) of this Form 4.
- F3The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $14.01 to $15.00, inclusive.
- F4All shares underlying this option are fully vested.